Cargando…
Update on the Use of PET/MRI Contrast Agents and Tracers in Brain Oncology: A Systematic Review
The recent advancements in hybrid positron emission tomography–magnetic resonance imaging systems (PET/MRI) have brought massive value in the investigation of disease processes, in the development of novel treatments, in the monitoring of both therapy response and disease progression, and, not least...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346926/ https://www.ncbi.nlm.nih.gov/pubmed/35937076 http://dx.doi.org/10.2147/IJN.S362192 |